The FDA Issues Warning on Docetaxel Drugs Including Taxotere
Docetaxel is a common intravenous chemotherapy drug administered to treat various types of cancer. A warning and advisory label has been issued by the Food and Drug Administration (FDA) revealing ethanol (alcohol) content in the drug has resulted in adverse health effects among patients.
This treatment comes in both generic and brand names, common ones being Taxotere, Docefrez, and the Docetaxel Injection. The Sanofi company has profited billions off of their product Taxotere, which is commonly used to treat patients with breast cancer.
Breast cancer patients who have suffered permanent hair loss (alopecia) and other negative side effects linked to docetaxel have begun to file lawsuits against Sanofi for their misinformation regarding their Taxotere products.
Don’t suffer in silence. Contact the compassionate National Taxotere attorneys today at (512) 476-7771 to receive your FREE, no-obligation legal consultation.
The Dangers of Docetaxel
Typical side effects of docetaxel can leave one feeling intoxicated during and after treatment, causing confusion, stumbling, and sleepiness. The alcohol content can also impair the central nervous system and have serious effects on those with pre-existing liver problems.
If the treatment is administered, patients should wait at least one to two hours after the transfusion to drive, operate machinery, or perform any activity that requires skill.
Health care professionals are advised to be extra cautious when prescribing docetaxel, especially when used in combination with other drugs.
Other likely side effects associated with Taxotere have been identified as the following:
- Permanent Alopecia (hair loss)
- Alcohol Intoxication
- Eye disorders
- Respiratory issues
Should adverse side effects manifest, speak with your physician about alternative options, lowering your dosage, or taking other steps to minimize associated health complications.
Talk To Your Physician About Taxotere Alternatives
Patients with breast cancer and other forms of cancer may have other options available for treatment. Physicians may recommend the following options for those continuing Taxotere or seeking alternative treatment:
- Reducing the speed of infusion to minimize symptoms of intoxication.
- Opting for a less ethanol-potent formula of the drug.
- Monitoring infusion and stopping when signs of intoxication become apparent.
- Counseling patients on the possible side effects and health complications that can arise, and offering alternative options.
If you have already begun to notice the negative side effects of Taxotere, know that Sanofi is directly liable for your damages, and you should be compensated.
Cancer Patients Most Likely To Use Docetaxel
Individuals who have a history of drinking or alcohol addiction should immediately inform their doctor. The same rings true for patients experiencing hepatic impairment as well. Docetaxel can further impair liver function and can result in heightened adverse conditions.
Individuals that are most likely to be prescribed docetaxel include patients with the following types of cancer:
- Breast cancer
- Prostate cancer
- Stomach cancer
- Head and neck cancers
- Non-small cell lung cancer
Get In Touch With Trustworthy Taxotere Lawsuit Attorneys
Patients suffering from different types of cancer have relied on docetaxel infusions to keep cancer cells from replicating, but unfortunately, docetaxel medications such as Taxotere can have a negative contribution to one’s health.
Sanofi violated federal drug regulations by falsely advertising this dangerous drug as safe. Those who have been harmed by Taxotere should seek out the unmatched legal experience of the Taxotere lawsuit attorneys of Hotze Runkle to win their maximum monetary compensation.
For more information and a FREE case review, contact the national Taxotere attorneys of Hotze Runkle by dialing in at (512) 476-7771 today.